Tuberculosis treatment has undergone recent changes in Brazil. Objective. To assess whether favorable outcomes on tuberculosis therapy improved in recent years. Methods. Retrospective observational study, based on primary data of tuberculosis patients, followed at INI-FIOCRUZ, from January 2012 to December 2014. Results. The outcomes observed were as follows: cure (80%), default (14%), treatment failure (5%), and death (1%). HIV infection without antiretroviral therapy [OR 0.34 (0.15-0.79)], tuberculosis diagnosis based on sputum smear [OR 0.22 (0.07-0.74)], drug use [OR 0.22 (0.11-0.46)], and/or treatment interruption due to adverse reactions [OR 0.23 (0.08-0.67)] decreased the chance of cure. Predictors of default, that is, use of noninjecting drugs [OR 3.00 (95% CL 1.31-6.88)], treatment interruption due to adverse reactions [OR 6.30 (1.81-21.95)], low schooling [OR 2.59 (2.15-5.82)], higher age [OR 0.44 (0.23-0.82)], and female gender [OR 0.28 (0.11-0.71)], reduced the chance of treatment default. Tuberculosis diagnosis based on sputum smear [OR 7.77 (1.94-31.09)] and/or arterial hypertension [OR 4.07 (1.25-13.18)] was associated with treatment failure. Conclusion. Mortality and default were low considering the prevalence of HIV infection; however cure was not significantly increased.